Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Operating Expenses: 2023-2025

Historic Operating Expenses for Camp4 Therapeutics (CAMP) over the last 2 years, with Sep 2025 value amounting to $14.4 million.

  • Camp4 Therapeutics' Operating Expenses rose 6.88% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.6 million, marking a year-over-year increase of 9.68%. This contributed to the annual value of $53.7 million for FY2024, which is 2.89% up from last year.
  • Latest data reveals that Camp4 Therapeutics reported Operating Expenses of $14.4 million as of Q3 2025, which was down 0.54% from $14.5 million recorded in Q2 2025.
  • Camp4 Therapeutics' 5-year Operating Expenses high stood at $14.7 million for Q4 2024, and its period low was $12.7 million during Q2 2024.
  • Moreover, its 3-year median value for Operating Expenses was $13.5 million (2024), whereas its average is $13.6 million.
  • Data for Camp4 Therapeutics' Operating Expenses shows a peak YoY increased of 14.71% (in 2025) over the last 5 years.
  • Over the past 3 years, Camp4 Therapeutics' Operating Expenses (Quarterly) stood at $13.5 million in 2023, then grew by 8.98% to $14.7 million in 2024, then climbed by 6.88% to $14.4 million in 2025.
  • Its Operating Expenses stands at $14.4 million for Q3 2025, versus $14.5 million for Q2 2025 and $14.0 million for Q1 2025.